Clinical Trial

Comparison of the Effectiveness of Dextrose Prolotherapy and Extracorporeal Shock Wave Therapy (ESWT) in Plantar Fasciitis

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 18, 2025 (before its estimated January 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
Plantar fasciitis is a degeneration of the plantar aponeurosis and is the most common cause of heel pain (11-15%). Although seen in both sexes, plantar fasciitis is more common in women, usually unilateral and bilateral in 30% of cases . The most widely accepted view regarding the formation of plantar fasciitis is that it is a degenerative process caused by myxoid degeneration, microtears, collagen necrosis, and angiofibroblastic hyperplasia, resulting from repetitive microtrauma to the plantar fascia, particularly at the calcaneal insertion site. It is not inflammatory . The purpose of this study was to compare the effectiveness of prolotherapy, a regenerative treatment, and ESWT in the treatment of plantar fasciitis.
Trial Details
NCT Number NCT07233395
Lead Sponsor Kanuni Sultan Suleyman Training and Research Hospital
Conditions Plantar Fasciitis
Enrollment 60 participants
Start Date 2025-11-15
Primary Completion 2026-01-15 (estimated)
Study Completion 2026-03-15 (estimated)
Updated on ClinicalTrials.gov 2025-11-18